Jaleh Barar
Research Center for Pharmaceutical Nanotechnology,
Faculty of Pharmacy,
School of Advanced Biomedical Sciences,
Research Center for Pharmaceutical Nanotechnology, Faculty of Pharmacy
Tabriz University (Medical Sciences)
Jaleh Barar has not added Biography.
If you are Jaleh Barar and would like to personalize this page please email our Author Liaison for assistance.
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies.
Brain research Nov, 2003 | Pubmed ID: 14568334
Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology.
Current drug delivery Oct, 2005 | Pubmed ID: 16305446
Expression and transport functionality of FcRn within rat alveolar epithelium: a study in primary cell culture and in the isolated perfused lung.
Pharmaceutical research Feb, 2006 | Pubmed ID: 16382279
Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures.
Biochemical and biophysical research communications Jul, 2007 | Pubmed ID: 17537407
Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Journal of drug targeting Jul, 2007 | Pubmed ID: 17613659
Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics Oct, 2007 | Pubmed ID: 17900230
Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells.
Cell biochemistry and function Apr, 2008 | Pubmed ID: 18210381
Ocular novel drug delivery: impacts of membranes and barriers.
Expert opinion on drug delivery May, 2008 | Pubmed ID: 18491982
Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
Human antibodies , 2009 | Pubmed ID: 19478394
Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures.
International journal of toxicology Mar-Apr, 2009 | Pubmed ID: 19482835
Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan).
Genetic testing and molecular biomarkers Oct, 2009 | Pubmed ID: 19715474
Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Human antibodies , 2009 | Pubmed ID: 19729803
Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells.
Toxicology mechanisms and methods , 2008 | Pubmed ID: 20020904
Barrier functionality and transport machineries of human ECV304 cells.
Medical science monitor : international medical journal of experimental and clinical research Jan, 2010 | Pubmed ID: 20037486
Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
Pharmaceutical development and technology Nov-Dec, 2011 | Pubmed ID: 20722498
Impacts of anti-EGFR monoclonal antibody in prostate cancer PC3 cells.
Human antibodies , 2010 | Pubmed ID: 20826931
A robust universal method for extraction of genomic DNA from bacterial species.
Mikrobiologiia Jul-Aug, 2010 | Pubmed ID: 21058509
Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells.
Journal of biomedical nanotechnology Aug, 2010 | Pubmed ID: 21323109
Molecular considerations for development of phage antibody libraries.
Journal of drug targeting Sep, 2011 | Pubmed ID: 21950316
Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities.
Journal of nanobiotechnology Jan, 2012 | Pubmed ID: 22221539
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。